Advisor Group’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $802K | Buy |
5,241
+561
| +12% | +$85.8K | 0.01% | 1348 |
|
|
2019
Q3 | $619K | Buy |
4,680
+204
| +5% | +$27K | ﹤0.01% | 1453 |
|
|
2019
Q2 | $636K | Buy |
4,476
+236
| +6% | +$33.5K | ﹤0.01% | 1448 |
|
|
2019
Q1 | $616K | Sell |
4,240
-234
| -5% | -$34K | 0.01% | 1446 |
|
|
2018
Q4 | $507K | Sell |
4,474
-139
| -3% | -$15.8K | 0.01% | 1397 |
|
|
2018
Q3 | $621K | Buy |
4,613
+2,470
| +115% | +$333K | 0.01% | 1310 |
|
|
2018
Q2 | $240K | Buy |
2,143
+60
| +3% | +$6.72K | ﹤0.01% | 1835 |
|
|
2018
Q1 | $222K | Buy |
2,083
+60
| +3% | +$6.4K | ﹤0.01% | 1895 |
|
|
2017
Q4 | $221K | Buy |
2,023
+485
| +32% | +$53K | ﹤0.01% | 1910 |
|
|
2017
Q3 | $165K | Buy |
1,538
+945
| +159% | +$101K | ﹤0.01% | 1995 |
|
|
2017
Q2 | $60K | Buy |
593
+230
| +63% | +$23.3K | ﹤0.01% | 2693 |
|
|
2017
Q1 | $33K | Buy |
363
+150
| +70% | +$13.6K | ﹤0.01% | 3010 |
|
|
2016
Q4 | $16K | Buy |
213
+4
| +2% | +$300 | ﹤0.01% | 3348 |
|
|
2016
Q3 | $17K | Sell |
209
-20
| -9% | -$1.63K | ﹤0.01% | 3244 |
|
|
2016
Q2 | $18K | Buy |
+229
| New | +$18K | ﹤0.01% | 3123 |
|